The Next Generation of Cell Therapy with Cartherics’ COO Dr. Ian Nisbet

In this episode of the Xtalks Life Science Podcast, we dive into the cutting edge of cell therapy innovation with Ian Nisbet, PhD, chief operating officer (COO) and co-founder of Cartherics, an Australian biotech company developing next-generation cell therapies for difficult-to-treat diseases like cancer and endometriosis.

Dr. Nisbet also acts as a director or advisor to several Australian and US biotechnology companies. With more than 35 years of leadership in biotech and experience in bringing two FDA-approved oncology drugs to market, Dr. Nisbet offers valuable insights into how the next generation of cell therapies could transform patient care.

Tune in to learn about Cartherics’ proprietary platform for generating an effectively unlimited supply of CAR-NK cells, the challenges and opportunities in developing treatments for underserved diseases and what’s next for the cell therapy industry worldwide.

For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/

Follow Us on Social Media

Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured